210 related articles for article (PubMed ID: 31471770)
1. Prognostic Role of Ki-67 in Adrenocortical Carcinoma After Primary Resection: A Retrospective Mono-Institutional Study.
Zhang F; Zhang F; Liu Z; Wu K; Zhu Y; Lu Y
Adv Ther; 2019 Oct; 36(10):2756-2768. PubMed ID: 31471770
[TBL] [Abstract][Full Text] [Related]
2. Association between preoperative serum albumin and prognosis in patients with adrenocortical carcinoma after primary resection: a retrospective study.
Zhang F; Liu Z; Liang J; Liu S; Wu K; Zhang F; Zhou C; Lu Y; Zhu Y; Wang X
BMC Cancer; 2021 Aug; 21(1):961. PubMed ID: 34445989
[TBL] [Abstract][Full Text] [Related]
3. Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection.
Beuschlein F; Weigel J; Saeger W; Kroiss M; Wild V; Daffara F; Libé R; Ardito A; Al Ghuzlan A; Quinkler M; Oßwald A; Ronchi CL; de Krijger R; Feelders RA; Waldmann J; Willenberg HS; Deutschbein T; Stell A; Reincke M; Papotti M; Baudin E; Tissier F; Haak HR; Loli P; Terzolo M; Allolio B; Müller HH; Fassnacht M
J Clin Endocrinol Metab; 2015 Mar; 100(3):841-9. PubMed ID: 25559399
[TBL] [Abstract][Full Text] [Related]
4. Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma.
Kim Y; Margonis GA; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem AI; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
JAMA Surg; 2016 Apr; 151(4):365-73. PubMed ID: 26676603
[TBL] [Abstract][Full Text] [Related]
5. Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma.
Duregon E; Cappellesso R; Maffeis V; Zaggia B; Ventura L; Berruti A; Terzolo M; Fassina A; Volante M; Papotti M
Hum Pathol; 2017 Apr; 62():1-7. PubMed ID: 27916625
[TBL] [Abstract][Full Text] [Related]
6. Survival and prognostic factors for adrenocortical carcinoma: a single institution experience.
Loncar Z; Djukic V; Zivaljevic V; Pekmezovic T; Diklic A; Tatic S; Dundjerovic D; Olujic B; Slijepcevic N; Paunovic I
BMC Urol; 2015 May; 15():43. PubMed ID: 26013141
[TBL] [Abstract][Full Text] [Related]
7. Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma.
Sbiera S; Sbiera I; Ruggiero C; Doghman-Bouguerra M; Korpershoek E; de Krijger RR; Ettaieb H; Haak H; Volante M; Papotti M; Reimondo G; Terzolo M; Luconi M; Nesi G; Mannelli M; Libé R; Ragazzon B; Assié G; Bertherat J; Altieri B; Fadda G; Rogowski-Lehmann N; Reincke M; Beuschlein F; Fassnacht M; Lalli E
J Clin Endocrinol Metab; 2017 Sep; 102(9):3491-3498. PubMed ID: 28911143
[TBL] [Abstract][Full Text] [Related]
8. Low Protein Expression of both
Brondani VB; Lacombe AMF; Mariani BMP; Montenegro L; Soares IC; Bezerra-Neto JE; Tanno FY; Srougi V; Chambo JL; Mendonca BB; Almeida MQ; Zerbini MCN; Fragoso MCBV
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513905
[TBL] [Abstract][Full Text] [Related]
9. Operative intervention for recurrence of adrenocortical carcinoma: A single-center experience.
Zhang F; Liu Z; Liang J; Tang Y; Liu S; Zhou C; Zhang F; Wu K; Lu Y; Wang X
Surgery; 2021 May; 169(5):1131-1138. PubMed ID: 33279225
[TBL] [Abstract][Full Text] [Related]
10. Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center.
Ayala-Ramirez M; Jasim S; Feng L; Ejaz S; Deniz F; Busaidy N; Waguespack SG; Naing A; Sircar K; Wood CG; Pagliaro L; Jimenez C; Vassilopoulou-Sellin R; Habra MA
Eur J Endocrinol; 2013 Dec; 169(6):891-899. PubMed ID: 24086089
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Possible Prognostic Markers for Patients Undergoing Resection of Adrenocortical Carcinoma.
de Jong MC; Mihai R; Khan S
World J Surg; 2021 Mar; 45(3):754-764. PubMed ID: 33221947
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer.
Berruti A; Fassnacht M; Haak H; Else T; Baudin E; Sperone P; Kroiss M; Kerkhofs T; Williams AR; Ardito A; Leboulleux S; Volante M; Deutschbein T; Feelders R; Ronchi C; Grisanti S; Gelderblom H; Porpiglia F; Papotti M; Hammer GD; Allolio B; Terzolo M
Eur Urol; 2014 Apr; 65(4):832-8. PubMed ID: 24268504
[TBL] [Abstract][Full Text] [Related]
13. Blood Transfusion and Survival for Resected Adrenocortical Carcinoma: A Study from the United States Adrenocortical Carcinoma Group.
Poorman CE; Postlewait LM; Ethun CG; Tran TB; Prescott JD; Pawlik TM; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Staley CA; Poultsides GA; Maithel SK
Am Surg; 2017 Jul; 83(7):761-768. PubMed ID: 28738949
[TBL] [Abstract][Full Text] [Related]
14. Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection.
Terzolo M; Baudin AE; Ardito A; Kroiss M; Leboulleux S; Daffara F; Perotti P; Feelders RA; deVries JH; Zaggia B; De Francia S; Volante M; Haak HR; Allolio B; Al Ghuzlan A; Fassnacht M; Berruti A
Eur J Endocrinol; 2013 Sep; 169(3):263-70. PubMed ID: 23704714
[TBL] [Abstract][Full Text] [Related]
15. Resection of adrenocortical carcinoma liver metastasis: is it justified?
Gaujoux S; Al-Ahmadie H; Allen PJ; Gonen M; Shia J; D'Angelica M; Dematteo R; Fong Y; Blumgart L; Jarnagin WR
Ann Surg Oncol; 2012 Aug; 19(8):2643-51. PubMed ID: 22526905
[TBL] [Abstract][Full Text] [Related]
16. Survival characteristics of localized pediatric adrenocortical carcinoma managed with adenectomy: A national cancer center database analysis.
Evanoff JD; Patel SG; Hickey KJ; Rensing AJ
J Pediatr Urol; 2021 Oct; 17(5):735.e1-735.e6. PubMed ID: 34210620
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma.
Bagante F; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
J Surg Oncol; 2015 Aug; 112(2):164-72. PubMed ID: 26234285
[TBL] [Abstract][Full Text] [Related]
18. The clinical utility of 'GRAS' parameters in stage I-III adrenocortical carcinomas: long-term data from a high-volume institution.
Liang J; Liu Z; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Wei X; Lu Y; Zhu Y
Endocrine; 2020 Feb; 67(2):449-456. PubMed ID: 31786772
[TBL] [Abstract][Full Text] [Related]
19. Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma.
Reibetanz J; Jurowich C; Erdogan I; Nies C; Rayes N; Dralle H; Behrend M; Allolio B; Fassnacht M;
Ann Surg; 2012 Feb; 255(2):363-9. PubMed ID: 22143204
[TBL] [Abstract][Full Text] [Related]
20. Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response.
Resende U; Cabello C; Ramalho SOB; Zeferino LC
BMC Cancer; 2019 Jun; 19(1):601. PubMed ID: 31208353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
